Senseonics Holdings, Inc. to Participate in the Stifel 2023 Healthcare Conference
09 11월 2023 - 10:05PM
Business Wire
Senseonics Holdings, Inc. (NYSE American: SENS), a medical
technology company focused on the development and manufacturing of
long-term, implantable continuous glucose monitoring (CGM) systems
for people with diabetes, today announced plans to participate in
the upcoming Stifel 2023 Healthcare Conference, taking place in New
York, NY.
Management is scheduled to present on Tuesday, November 14, 2023
from 4:45pm to 5:15pm ET. Interested parties may access a live and
recorded webcast of the presentation on the “Investor Relations”
section of the company’s website at www.senseonics.com.
About Senseonics
Senseonics Holdings, Inc. (“Senseonics”) is a medical technology
company focused on the development and manufacturing of glucose
monitoring products designed to transform lives in the global
diabetes community with differentiated, long-term implantable
glucose management technology. Senseonics' CGM systems, Eversense®,
Eversense® XL and Eversense® E3 include a small sensor inserted
completely under the skin that communicates with a smart
transmitter worn over the sensor. The glucose data are
automatically sent every 5 minutes to a mobile app on the user's
smartphone.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231109796898/en/
Philip Taylor Gilmartin Group 415-937-5406
Investors@senseonics.com
Senseonics (AMEX:SENS)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Senseonics (AMEX:SENS)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
